Estados Unidos - inglés - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - oxymorphone hydrochloride (unii: 5y2ei94nbc) (oxymorphone - unii:9vxa968e0c) - oxymorphone hydrochloride 5 mg

Estados Unidos - inglés - NLM (National Library of Medicine)

actavis pharma, inc. - oxymorphone hydrochloride (unii: 5y2ei94nbc) (oxymorphone - unii:9vxa968e0c) - oxymorphone hydrochloride 5 mg

Estados Unidos - inglés - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - oxymorphone hydrochloride (unii: 5y2ei94nbc) (oxymorphone - unii:9vxa968e0c) - oxymorphone hydrochloride 15 mg

Estados Unidos - inglés - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - oxymorphone hydrochloride (unii: 5y2ei94nbc) (oxymorphone - unii:9vxa968e0c) - oxymorphone hydrochloride 5 mg

Estados Unidos - inglés - NLM (National Library of Medicine)

american health packaging - oxymorphone hydrochloride (unii: 5y2ei94nbc) (oxymorphone - unii:9vxa968e0c) - oxymorphone hydrochloride 10 mg

Estados Unidos - inglés - NLM (National Library of Medicine)

corepharma, llc - oxymorphone hydrochloride (unii: 5y2ei94nbc) (oxymorphone - unii:9vxa968e0c) - oxymorphone hydrochloride 5 mg

Estados Unidos - inglés - NLM (National Library of Medicine)

endo pharmaceuticals inc. - oxymorphone hydrochloride (unii: 5y2ei94nbc) (oxymorphone - unii:9vxa968e0c) - oxymorphone hydrochloride 5 mg - opana is indicated for the management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see warnings and precautions (5.1) ], reserve opana for use in patients for whom alternative treatment options [e.g., non-opioid analgesics or opioid combination products]: - have not been tolerated, or are not expected to be tolerated, - have not provided adequate analgesia, or are not expected to provide adequate analgesia opana is contraindicated in patients with: - significant respiratory depression [see warnings and precautions (5.3) ] - acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings and precautions (5.6) ] - known or suspected gastrointestinal obstruction, including paralytic ileus [see warnings and precautions (5.11) ] - hypersensitivity to oxymorphone (e.g., anaphylaxis, an

Estados Unidos - inglés - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - oxymorphone hydrochloride (unii: 5y2ei94nbc) (oxymorphone - unii:9vxa968e0c) - oxymorphone hydrochloride 10 mg - opana er is an opioid agonist indicated for the relief of moderate to severe pain in patients requiring continuous around-the-clock opioid treatment for an extended period of time. (1) limitations of use - opana er is not for use:             •    as an as-needed (prn) analgesic             •    for pain that is mild or not expected to persist for an extended period of time             •    for acute pain             •    for postoperative pain, unless the patient is already receiving chronic opioid therapy prior to surgery, or if the postoperative                   pain is expected to be moderate to severe and persist for an extended period of time. opana er is contraindicated in patients with: - significant respiratory depression - acute or severe bronchial asthma or hypercarbia - known or suspected paralytic ileus - moderate and severe hepatic impairment [see clinical pharmacology (12.3), warnings and precautions (5.8)] . - hypersensitivity (e.g. anaphylaxis) to oxymorphone, any other ingredients in

Estados Unidos - inglés - NLM (National Library of Medicine)

endo pharmaceuticals inc. - oxymorphone hydrochloride (unii: 5y2ei94nbc) (oxymorphone - unii:9vxa968e0c) - oxymorphone hydrochloride 5 mg - opana er is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. limitations of use - because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with extended-release opioid formulations [see warnings and precautions (5.1)] , reserve opana er for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or immediate-release opioids) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. - opana er is not indicated as an as-needed (prn) analgesic. opana er is contraindicated in patients with: - significant respiratory depression [see warnings and precautions (5.3)] - acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings and precautions (5.6)] - hypersensitivity t

Estados Unidos - inglés - NLM (National Library of Medicine)

rebel distributors corp - oxymorphone hydrochloride (unii: 5y2ei94nbc) (oxymorphone - unii:9vxa968e0c) - oxymorphone hydrochloride 5 mg - opana er is indicated for the relief of moderate to severe pain in patients requiring continuous, around-the-clock opioid treatment for an extended period of time. opana er is not intended for use as a prn analgesic. opana er is not indicated for pain in the immediate post-operative period (12-24 hours following surgery) for patients not previously taking opioids because of the risk of oversedation and respiratory depression requiring reversal with opioid antagonists. opana er is not indicated for pain in the post-operative period if the pain is mild or not expected to persist for an extended period of time. opana er is contraindicated in patients with a known hypersensitivity to oxymorphone hydrochloride or to any of the other ingredients in opana er, or with known hypersensitivity to morphine analogs such as codeine. opana er is not indicated for pain in the immediate post-operative period (the first 12-24 hours following surgery), or if the pain is mild, or not expected to persist for an extended period of